Data:
{
"symbol": "EYPT",
"price": 4.525,
"marketCap": 379381873,
"beta": 1.739,
"lastDividend": 0,
"range": "3.95-19.11",
"change": -10.225,
"changePercentage": -69.32203,
"volume": 30984272.93951,
"averageVolume": 1282613,
"companyName": "EyePoint Pharmaceuticals, Inc.",
"currency": "USD",
"cik": "0001314102",
"isin": "US30233G2093",
"cusip": "30233G209",
"exchangeFullName": "NASDAQ Global Market",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.eyepoint.bio",
"description": "EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom. Among its commercialized product portfolio are ILUVIEN, an injectable, sustained-release micro-insert designed to treat diabetic macular edema, and YUTIQ, an intravitreal implant containing fluocinolone acetonide, which targets chronic non-infectious uveitis impacting the posterior segment of the eye. The company also offers DEXYCU, a dexamethasone intraocular suspension, utilized to manage post-operative ocular inflammation, such as that occurring after cataract surgery. Looking ahead, EyePoint is actively developing several pipeline therapies. This includes EYP-1901, a novel, bioerodible tyrosine kinase inhibitor currently formulated for twice-yearly administration, which is under development for conditions like wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. Additionally, YUTIQ50 is being advanced as a treatment for chronic non-infectious uveitis affecting the posterior region of the eye. To bolster its market reach and development efforts, the company maintains strategic alliances with entities such as Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. Furthermore, a commercial collaboration with ImprimisRx PA, Inc. specifically focuses on the joint promotion of DEXYCU for inflammation following ocular surgery. Incorporated in 1987, the organization was previously known as pSivida Corp. before officially rebranding as EyePoint Pharmaceuticals, Inc. in March 2018. Its corporate headquarters are situated in Watertown, Massachusetts.",
"ceo": "Jay S. Duker",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "214",
"phone": "617 926 5000",
"address": "480 Pleasant Street",
"city": "Watertown",
"state": "MA",
"zip": "02472",
"image": "https://images.financialmodelingprep.com/symbol/EYPT.png",
"ipoDate": "2005-01-27",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "EYPT",
"name": "EyePoint Pharmaceuticals, Inc.",
"price": 5.2709,
"changePercentage": 8.23203,
"change": 0.4009,
"volume": 7647577.8819,
"dayLow": 4.7032,
"dayHigh": 5.49,
"yearHigh": 19.11,
"yearLow": 3.95,
"marketCap": 441919098,
"priceAvg50": 13.0098,
"priceAvg200": 14.1165,
"exchange": "NASDAQ",
"open": 4.71,
"previousClose": 4.87,
"timestamp": 1787064154,
"chart_vwap_daily": [
{
"t": "2026-07-08",
"v": 14.0304,
"c": 14.01
},
{
"t": "2026-07-09",
"v": 14.709,
"c": 14.84
},
{
"t": "2026-07-10",
"v": 14.4631,
"c": 14.72
},
{
"t": "2026-07-13",
"v": 14.1504,
"c": 14.28
},
{
"t": "2026-07-14",
"v": 14.0378,
"c": 13.73
},
{
"t": "2026-07-15",
"v": 13.7613,
"c": 13.85
},
{
"t": "2026-07-16",
"v": 13.2043,
"c": 13.04
},
{
"t": "2026-07-17",
"v": 13.393,
"c": 13.3
},
{
"t": "2026-07-20",
"v": 12.8378,
"c": 12.66
},
{
"t": "2026-07-21",
"v": 12.9876,
"c": 13.05
},
{
"t": "2026-07-22",
"v": 12.6779,
"c": 12.66
},
{
"t": "2026-07-23",
"v": 12.4869,
"c": 12.47
},
{
"t": "2026-07-24",
"v": 12.1958,
"c": 12.19
},
{
"t": "2026-07-27",
"v": 12.4723,
"c": 12.41
},
{
"t": "2026-07-28",
"v": 11.8955,
"c": 11.96
},
{
"t": "2026-07-29",
"v": 11.9487,
"c": 11.92
},
{
"t": "2026-07-30",
"v": 12.6264,
"c": 12.86
},
{
"t": "2026-07-31",
"v": 12.2385,
"c": 12.25
},
{
"t": "2026-08-03",
"v": 12.2855,
"c": 12.42
},
{
"t": "2026-08-04",
"v": 11.9955,
"c": 11.67
},
{
"t": "2026-08-05",
"v": 12.2222,
"c": 12.25
},
{
"t": "2026-08-06",
"v": 12.5192,
"c": 12.83
},
{
"t": "2026-08-07",
"v": 13.7925,
"c": 13.89
},
{
"t": "2026-08-10",
"v": 13.2871,
"c": 13.07
},
{
"t": "2026-08-11",
"v": 12.7087,
"c": 13.05
},
{
"t": "2026-08-12",
"v": 13.494,
"c": 13.53
},
{
"t": "2026-08-13",
"v": 13.4331,
"c": 13.48
},
{
"t": "2026-08-14",
"v": 14.2532,
"c": 14.75
},
{
"t": "2026-08-17",
"v": 4.5216,
"c": 4.87
},
{
"t": "2026-08-18",
"v": 5.1872,
"c": 5.31
}
],
"vwap_summary": {
"days": 30,
"days_above": 18,
"days_below": 12,
"pct_days_above": 60,
"position": "above",
"gap_pct": 2.37,
"streak_days": 6
}
}
Data:
{
"volume": 7647577.8819,
"avgVolume": 1282613,
"short_ratio": [
{
"symbol": "EYPT",
"file_date": "2026-08-17",
"date": "20260817",
"short_volume": 14195232,
"short_exempt_volume": 1866705,
"total_volume": 26364523,
"short_volume_ratio": 0.5384,
"signal": "Neutral"
}
],
"volume_profile": {
"poc": 4.57,
"vah": 12.07,
"val": 4.12,
"profile": [
{
"price": 4.21,
"volume": 11701059
},
{
"price": 4.39,
"volume": 7996191
},
{
"price": 4.57,
"volume": 17578709
},
{
"price": 4.74,
"volume": 5913212
},
{
"price": 4.92,
"volume": 1758440
},
{
"price": 5.1,
"volume": 2139164
},
{
"price": 5.27,
"volume": 3701373
},
{
"price": 5.45,
"volume": 1210735
},
{
"price": 5.63,
"volume": 0
},
{
"price": 5.8,
"volume": 0
},
{
"price": 5.98,
"volume": 0
},
{
"price": 6.16,
"volume": 0
},
{
"price": 6.33,
"volume": 0
},
{
"price": 6.51,
"volume": 0
},
{
"price": 6.69,
"volume": 0
},
{
"price": 6.86,
"volume": 0
},
{
"price": 7.04,
"volume": 0
},
{
"price": 7.22,
"volume": 0
},
{
"price": 7.39,
"volume": 0
},
{
"price": 7.57,
"volume": 0
},
{
"price": 7.75,
"volume": 0
},
{
"price": 7.92,
"volume": 0
},
{
"price": 8.1,
"volume": 0
},
{
"price": 8.28,
"volume": 0
},
{
"price": 8.45,
"volume": 0
},
{
"price": 8.63,
"volume": 0
},
{
"price": 8.81,
"volume": 0
},
{
"price": 8.98,
"volume": 0
},
{
"price": 9.16,
"volume": 0
},
{
"price": 9.34,
"volume": 0
},
{
"price": 9.51,
"volume": 0
},
{
"price": 9.69,
"volume": 0
},
{
"price": 9.87,
"volume": 0
},
{
"price": 10.04,
"volume": 0
},
{
"price": 10.22,
"volume": 0
},
{
"price": 10.4,
"volume": 0
},
{
"price": 10.57,
"volume": 0
},
{
"price": 10.75,
"volume": 0
},
{
"price": 10.93,
"volume": 0
},
{
"price": 11.1,
"volume": 0
},
{
"price": 11.28,
"volume": 0
},
{
"price": 11.46,
"volume": 0
},
{
"price": 11.63,
"volume": 911718
},
{
"price": 11.81,
"volume": 1792091
},
{
"price": 11.99,
"volume": 2462718
},
{
"price": 12.16,
"volume": 4813995
},
{
"price": 12.34,
"volume": 2414233
},
{
"price": 12.52,
"volume": 3520245
},
{
"price": 12.69,
"volume": 2336787
},
{
"price": 12.87,
"volume": 1302616
},
{
"price": 13.05,
"volume": 987164
},
{
"price": 13.22,
"volume": 417940
},
{
"price": 13.4,
"volume": 1483298
},
{
"price": 13.58,
"volume": 2037130
},
{
"price": 13.75,
"volume": 765633
},
{
"price": 13.93,
"volume": 878847
},
{
"price": 14.11,
"volume": 590548
},
{
"price": 14.28,
"volume": 249101
},
{
"price": 14.46,
"volume": 314115
},
{
"price": 14.64,
"volume": 520346
}
],
"sessions": 20
}
}
Data:
{
"symbol": "EYPT",
"marketCap": 440166815,
"enterpriseValueTTM": 352075815,
"evToSalesTTM": 126.23729472929365,
"evToOperatingCashFlowTTM": -1.3171659159440026,
"evToFreeCashFlowTTM": -1.2978365999579768,
"evToEBITDATTM": -1.1958731390684387,
"netDebtToEBITDATTM": 0.2992129996025937,
"currentRatioTTM": 4.501752378227595,
"incomeQualityTTM": 0.8716911848631796,
"grahamNumberTTM": null,
"grahamNetNetTTM": 1.383098575274719,
"taxBurdenTTM": 1.0004437092790703,
"interestBurdenTTM": 1.0297737237312907,
"workingCapitalTTM": 146874000,
"investedCapitalTTM": 176730000,
"returnOnAssetsTTM": -1.3437997116450693,
"operatingReturnOnAssetsTTM": -1.2276184722157675,
"returnOnTangibleAssetsTTM": -1.3437997116450693,
"returnOnEquityTTM": -1.358062308869348,
"returnOnInvestedCapitalTTM": -1.6781444738510782,
"returnOnCapitalEmployedTTM": -1.7019028392251192,
"earningsYieldTTM": -0.6749036949977523,
"freeCashFlowYieldTTM": -0.6163095234700963,
"capexToOperatingCashFlowTTM": -0.014893489663222322,
"capexToDepreciationTTM": 1.531153846153846,
"capexToRevenueTTM": 1.4273933309429903,
"salesGeneralAndAdministrativeToRevenueTTM": 19.867694514162782,
"researchAndDevelopementToRevenueTTM": 94.20222301900323,
"stockBasedCompensationToRevenueTTM": 12.62567228397275,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 621500,
"averagePayablesTTM": 18040000,
"averageInventoryTTM": 1566000,
"daysOfSalesOutstandingTTM": 11.254930082466833,
"daysOfPayablesOutstandingTTM": 3880.8220443349755,
"daysOfInventoryOutstandingTTM": 422.98645320197045,
"operatingCycleTTM": 434.2413832844373,
"cashConversionCycleTTM": -3446.5806610505383,
"freeCashFlowToEquityTTM": -271390000,
"freeCashFlowToFirmTTM": -271279000,
"tangibleAssetValueTTM": 166411000,
"netCurrentAssetValueTTM": 127037000,
"grossProfitMarginTTM": 0.417712441735389,
"ebitMarginTTM": -106.72104697024022,
"ebitdaMarginTTM": -105.56077447113661,
"operatingProfitMarginTTM": -113.65220509143062,
"pretaxProfitMarginTTM": -109.89852993904626,
"continuousOperationsProfitMarginTTM": -109.84976694155611,
"netProfitMarginTTM": -109.9472929365364,
"bottomLineProfitMarginTTM": -109.9472929365364,
"receivablesTurnoverTTM": 32.43023255813954,
"payablesTurnoverTTM": 0.09405223837377656,
"inventoryTurnoverTTM": 0.8629117959617428,
"fixedAssetTurnoverTTM": 0.09341505894962486,
"assetTurnoverTTM": 0.01222221735300691,
"quickRatioTTM": 4.456881958848914,
"solvencyRatioTTM": -4.9110877306571705,
"cashRatioTTM": 2.6335264525665782,
"priceToEarningsRatioTTM": -1.4037433155080212,
"priceToEarningsGrowthRatioTTM": 0.0457649410088751,
"forwardPriceToEarningsGrowthRatioTTM": 0.07167191450376074,
"priceToEarningsDilutedRatioTTM": -1.4037433155080212,
"priceToEarningsDilutedGrowthRatioTTM": 0.0457649410088751,
"priceToBookRatioTTM": 2.7302927691078116,
"priceToSalesRatioTTM": 157.82245069917533,
"priceToFreeCashFlowRatioTTM": -1.6225613298486061,
"priceToOperatingCashFlowRatioTTM": -1.699791057172145,
"debtToAssetsRatioTTM": 0.09801876498196686,
"debtToEquityRatioTTM": 0.13440818215142028,
"debtToCapitalRatioTTM": 0.1184830859528123,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.3712494967279807,
"workingCapitalTurnoverRatioTTM": 0.015541154246931053,
"operatingCashFlowRatioTTM": -6.372887013327611,
"operatingCashFlowSalesRatioTTM": -95.84008605234851,
"freeCashFlowOperatingCashFlowRatioTTM": 1.0148934896632222,
"debtServiceCoverageRatioTTM": 0,
"interestCoverageRatioTTM": 0,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -11.950552152724997,
"capitalExpenditureCoverageRatioTTM": -67.14343129866867,
"dividendPaidAndCapexCoverageRatioTTM": -67.14343129866867,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0.03222675433021735,
"netIncomePerShareTTM": -3.5432443987381994,
"interestDebtPerShareTTM": 0.2584495568676843,
"cashPerShareTTM": 2.085344857469697,
"bookValuePerShareTTM": 1.9228707116693435,
"tangibleBookValuePerShareTTM": 1.9228707116693435,
"shareholdersEquityPerShareTTM": 1.9228707116693435,
"operatingCashFlowPerShareTTM": -3.0886149081959258,
"capexPerShareTTM": 0.04600025420889038,
"freeCashFlowPerShareTTM": -3.134615162404816,
"netIncomePerEBTTTM": 1.0004437092790703,
"ebtPerEbitTTM": 0.9669722628842562,
"priceToFairValueTTM": 2.7302927691078116,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": 0.0004437092790702986,
"enterpriseValueMultipleTTM": -1.1958731390684387,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 31371000
}
],
"dcf": {
"symbol": "EYPT",
"date": "2026-08-18",
"dcf": -2.6671403124907584,
"Stock Price": 4.87
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "EYPT",
"reportedCurrency": "USD",
"cik": "0001314102",
"filingDate": "2026-03-05",
"acceptedDate": "2026-03-05 16:06:01",
"fiscalYear": "2025",
"period": "FY",
"revenue": 31371000,
"costOfRevenue": 2066000,
"grossProfit": 29305000,
"researchAndDevelopmentExpenses": 221039000,
"generalAndAdministrativeExpenses": 51610000,
"sellingAndMarketingExpenses": 90000,
"sellingGeneralAndAdministrativeExpenses": 51700000,
"otherExpenses": 0,
"operatingExpenses": 272739000,
"costAndExpenses": 274805000,
"netInterestIncome": 11751000,
"interestIncome": 11751000,
"interestExpense": -33000,
"depreciationAndAmortization": 2309000,
"ebitda": -229341000,
"ebit": -231650000,
"nonOperatingIncomeExcludingInterest": -11784000,
"operatingIncome": -243434000,
"totalOtherIncomeExpensesNet": 11751000,
"incomeBeforeTax": -231683000,
"incomeTaxExpense": 279000,
"netIncomeFromContinuingOperations": -231962000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": -558000,
"netIncome": -231962000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -231962000,
"eps": -3.17,
"epsDiluted": -3.17,
"weightedAverageShsOut": 73251000,
"weightedAverageShsOutDil": 73251000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "EYPT",
"reportedCurrency": "USD",
"cik": "0001314102",
"filingDate": "2026-03-05",
"acceptedDate": "2026-03-05 16:06:01",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 101821000,
"shortTermInvestments": 204265000,
"cashAndShortTermInvestments": 306086000,
"netReceivables": 651000,
"accountsReceivables": 651000,
"otherReceivables": 0,
"inventory": 1813000,
"prepaids": 0,
"otherCurrentAssets": 20105000,
"totalCurrentAssets": 328655000,
"propertyPlantEquipmentNet": 20223000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 15118000,
"totalNonCurrentAssets": 35341000,
"otherAssets": 0,
"totalAssets": 363996000,
"totalPayables": 10490000,
"accountPayables": 10490000,
"otherPayables": 0,
"accruedExpenses": 24332000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 2021999,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 180000,
"totalCurrentLiabilities": 37024000,
"longTermDebt": 0,
"capitalLeaseObligationsNonCurrent": 20772000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 87000,
"totalNonCurrentLiabilities": 20859000,
"otherLiabilities": 0,
"capitalLeaseObligations": 22793999,
"totalLiabilities": 57883000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 83000,
"retainedEarnings": -1104978000,
"additionalPaidInCapital": 1410047000,
"accumulatedOtherComprehensiveIncomeLoss": 961000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 306113000,
"totalEquity": 306113000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 363996000,
"totalInvestments": 204265000,
"totalDebt": 22793999,
"netDebt": -79027000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "EYPT",
"reportedCurrency": "USD",
"cik": "0001314102",
"filingDate": "2026-03-05",
"acceptedDate": "2026-03-05 16:06:01",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -231962000,
"depreciationAndAmortization": 2309000,
"deferredIncomeTax": 279000,
"stockBasedCompensation": 27873000,
"changeInWorkingCapital": -33781000,
"accountsReceivables": -10667000,
"inventory": 492000,
"accountsPayables": 4677000,
"otherWorkingCapital": -28283000,
"otherNonCashItems": -4828000,
"netCashProvidedByOperatingActivities": -240110000,
"investmentsInPropertyPlantAndEquipment": -3280000,
"acquisitionsNet": 155000,
"purchasesOfInvestments": -252020000,
"salesMaturitiesOfInvestments": 318897000,
"otherInvestingActivities": 4828000,
"netCashProvidedByInvestingActivities": 68580000,
"netDebtIssuance": -105000,
"longTermNetDebtIssuance": -105000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 175140000,
"netCommonStockIssuance": 175140000,
"commonStockIssuance": 175140000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -1388000,
"netCashProvidedByFinancingActivities": 173647000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": 2117000,
"cashAtEndOfPeriod": 101971000,
"cashAtBeginningOfPeriod": 99854000,
"operatingCashFlow": -240110000,
"capitalExpenditure": -3280000,
"freeCashFlow": -243390000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 5.285,
"rsi": 26.98054042183979,
"sma20": 11.990749999999998,
"sma50": 12.879900000000003,
"sma200": 14.084274999999986,
"adx": 19.217560706122697,
"atr": 1.66,
"atr_pct": 31.41,
"high_52w": 29.71,
"low_52w": 2.28,
"structure": {
"ema8": 10.169106412486478,
"ema21": 11.742366243417196,
"ema50": 12.565601022244868,
"ema200": 13.1232704419477,
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": -55.0,
"macd": {
"macd": -1.032,
"signal": -0.35,
"histogram": -0.681
},
"bollinger": {
"mid": 11.99,
"upper": 16.82,
"lower": 7.16,
"width_pct": 80.53
},
"crossover": {
"fresh_cross": true,
"pre_compressed": true,
"held_above_21": false,
"candles_since": 4,
"intraday_support": false
},
"momentum": {
"roc10": -54.7,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": false,
"near_high": false
},
"volume": {
"rvol": 1.64,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": true,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 2.96,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": false,
"avg_vol_over_2m": false,
"mcap_over_1b": false,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": false
},
"avg_dollar_vol": 5803823.825,
"avg_vol": 1282613
},
"options": {
"checks": {
"call_vol_2x": true,
"ivr_under_40": true,
"iv_contracting": true,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 2.1,
"iv_rank": 23.0
}
}
}
}
Data:
{
"prior_day": {
"high": 5.49,
"low": 4.7,
"close": 5.31,
"date": "2026-08-18"
},
"woodie_pivots": {
"PP": 5.2,
"R1": 5.7,
"S1": 4.92,
"R2": 5.99,
"S2": 4.42
},
"swing": {
"high_20d": 14.76,
"low_20d": 3.95,
"high_60d": 15.92,
"low_60d": 3.95
},
"orb": {
"high": 5.49,
"low": 4.7,
"date": "2026-08-18"
},
"vwap": 5.22,
"volume_profile": {
"poc": 4.57,
"vah": 12.07,
"val": 4.12,
"sessions": 20
},
"recent_daily": [
{
"d": "2026-07-15",
"o": 13.73,
"h": 14,
"l": 13.41,
"c": 13.85,
"v": 1484510.211335
},
{
"d": "2026-07-16",
"o": 14.14,
"h": 14.2,
"l": 12.86,
"c": 13.04,
"v": 1551216.339378
},
{
"d": "2026-07-17",
"o": 12.76,
"h": 13.69,
"l": 12.61,
"c": 13.3,
"v": 1283890.096865
},
{
"d": "2026-07-20",
"o": 13.27,
"h": 13.79,
"l": 12.65,
"c": 12.66,
"v": 1099731.725452
},
{
"d": "2026-07-21",
"o": 12.66,
"h": 13.23,
"l": 12.45,
"c": 13.05,
"v": 1585308.933797
},
{
"d": "2026-07-22",
"o": 12.81,
"h": 13.04,
"l": 12.52,
"c": 12.66,
"v": 1063990.75806
},
{
"d": "2026-07-23",
"o": 12.45,
"h": 12.89,
"l": 12.295,
"c": 12.47,
"v": 1284723.792337
},
{
"d": "2026-07-24",
"o": 12.45,
"h": 12.4975,
"l": 12.06,
"c": 12.19,
"v": 1468697.330602
},
{
"d": "2026-07-27",
"o": 12.48,
"h": 13.025,
"l": 12.17,
"c": 12.41,
"v": 1390307.288131
},
{
"d": "2026-07-28",
"o": 12.34,
"h": 12.53,
"l": 11.72,
"c": 11.96,
"v": 1698346.117873
},
{
"d": "2026-07-29",
"o": 11.98,
"h": 12.355,
"l": 11.555,
"c": 11.92,
"v": 2054155.291492
},
{
"d": "2026-07-30",
"o": 12.17,
"h": 13,
"l": 11.79,
"c": 12.86,
"v": 1561104.09591
},
{
"d": "2026-07-31",
"o": 12.81,
"h": 12.83,
"l": 12.04,
"c": 12.25,
"v": 1711475.698434
},
{
"d": "2026-08-03",
"o": 12.34,
"h": 12.51,
"l": 12.02,
"c": 12.42,
"v": 1479461.891767
},
{
"d": "2026-08-04",
"o": 12.44,
"h": 12.7,
"l": 11.54,
"c": 11.67,
"v": 2929693.09765
},
{
"d": "2026-08-05",
"o": 11.88,
"h": 12.74,
"l": 11.849,
"c": 12.25,
"v": 2450067.802929
},
{
"d": "2026-08-06",
"o": 12.25,
"h": 13.03,
"l": 12.005,
"c": 12.83,
"v": 2240810.625411
},
{
"d": "2026-08-07",
"o": 13.04,
"h": 14.08,
"l": 13.0286,
"c": 13.89,
"v": 1655696.904891
},
{
"d": "2026-08-10",
"o": 14.22,
"h": 14.32,
"l": 13.02,
"c": 13.07,
"v": 1757173.011253
},
{
"d": "2026-08-11",
"o": 13.105,
"h": 13.105,
"l": 12.37,
"c": 13.05,
"v": 2058473.958297
},
{
"d": "2026-08-12",
"o": 13.05,
"h": 13.77,
"l": 13.02,
"c": 13.53,
"v": 2261368.941293
},
{
"d": "2026-08-13",
"o": 13.59,
"h": 13.6938,
"l": 13.25,
"c": 13.48,
"v": 1202186.264542
},
{
"d": "2026-08-14",
"o": 13.53,
"h": 14.76,
"l": 13.4,
"c": 14.75,
"v": 2511098.410988
},
{
"d": "2026-08-17",
"o": 4.06,
"h": 4.9,
"l": 3.95,
"c": 4.87,
"v": 52268276.910061
},
{
"d": "2026-08-18",
"o": 4.73,
"h": 5.49,
"l": 4.7032,
"c": 5.31,
"v": 7634637.580603
}
]
}
Data:
{
"estimates": [
{
"symbol": "EYPT",
"date": "2030-12-31",
"revenueLow": 58621733,
"revenueHigh": 2589204732,
"revenueAvg": 916957875,
"ebitdaLow": -2589204732,
"ebitdaHigh": -58621733,
"ebitdaAvg": -916957875,
"ebitLow": -2589204732,
"ebitHigh": -58621733,
"ebitAvg": -916957875,
"netIncomeLow": -44643555,
"netIncomeHigh": 693829086,
"netIncomeAvg": 205835312,
"sgaExpenseLow": 80667179,
"sgaExpenseHigh": 3562908007,
"sgaExpenseAvg": 1261791512,
"epsAvg": 2.81,
"epsHigh": 9.47194,
"epsLow": -0.60946,
"numAnalystsRevenue": 4,
"numAnalystsEps": 4
},
{
"symbol": "EYPT",
"date": "2029-12-31",
"revenueLow": 36708075,
"revenueHigh": 1621322294,
"revenueAvg": 574185667,
"ebitdaLow": -1621322294,
"ebitdaHigh": -36708075,
"ebitdaAvg": -574185667,
"ebitLow": -1621322294,
"ebitHigh": -36708075,
"ebitAvg": -574185667,
"netIncomeLow": -7873017,
"netIncomeHigh": 122360669,
"netIncomeAvg": 36300266,
"sgaExpenseLow": 50512612,
"sgaExpenseHigh": 2231041103,
"sgaExpenseAvg": 790115468,
"epsAvg": 0.49556,
"epsHigh": 1.67043,
"epsLow": -0.10748,
"numAnalystsRevenue": 4,
"numAnalystsEps": 2
},
{
"symbol": "EYPT",
"date": "2028-12-31",
"revenueLow": 16089253,
"revenueHigh": 710630156,
"revenueAvg": 251667205,
"ebitdaLow": -710630156,
"ebitdaHigh": -16089253,
"ebitdaAvg": -251667205,
"ebitLow": -710630156,
"ebitHigh": -16089253,
"ebitAvg": -251667205,
"netIncomeLow": -267302425,
"netIncomeHigh": 63639004,
"netIncomeAvg": -190315720,
"sgaExpenseLow": 22139820,
"sgaExpenseHigh": 977871638,
"sgaExpenseAvg": 346309849,
"epsAvg": -1.61546,
"epsHigh": 0.86878,
"epsLow": -3.64913,
"numAnalystsRevenue": 9,
"numAnalystsEps": 7
},
{
"symbol": "EYPT",
"date": "2027-12-31",
"revenueLow": 487469,
"revenueHigh": 86217095,
"revenueAvg": 29467528,
"ebitdaLow": -86217095,
"ebitdaHigh": -487469,
"ebitdaAvg": -29467528,
"ebitLow": -86217095,
"ebitHigh": -487469,
"ebitAvg": -29467528,
"netIncomeLow": -289779494,
"netIncomeHigh": -134817002,
"netIncomeAvg": -262494100,
"sgaExpenseLow": 670787,
"sgaExpenseHigh": 118640126,
"sgaExpenseAvg": 40549165,
"epsAvg": -3.01458,
"epsHigh": -1.84048,
"epsLow": -3.95598,
"numAnalystsRevenue": 9,
"numAnalystsEps": 9
}
],
"price_target": {
"symbol": "EYPT",
"targetHigh": 40,
"targetLow": 5,
"targetConsensus": 20.67,
"targetMedian": 17.5
},
"ratings": {
"symbol": "EYPT",
"rating": "C-",
"overallScore": 1,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 3,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "EYPT",
"date": "2026-08-17",
"gradingCompany": "Jefferies",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-08-17",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Neutral",
"action": "downgrade"
},
{
"symbol": "EYPT",
"date": "2026-08-17",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-08-07",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-08-06",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-08-06",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-07-01",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-06-24",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-05-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-03-09",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-03-05",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2026-03-04",
"gradingCompany": "Chardan Capital",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "EYPT",
"date": "2025-11-06",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
}
]
}
Data:
[
{
"title": "RBC Capital Downgrades EyePoint to Sector Perform, Lowers Price Target to $5",
"url": "https://www.benzinga.com/news/26/08/61271048/rbc-capital-downgrades-eyepoint-sector-perform-lowers-price-target-5",
"source": "benzinga",
"date": "2026-08-18T12:39:47.151000+00:00",
"summary": "RBC Capital analyst Lisa Walter downgrades EyePoint (NASDAQ:EYPT) from Outperform to Sector Perform and lowers the price target from $37 to $5.",
"image": ""
},
{
"title": "Chardan Capital Downgrades EyePoint to Neutral, Lowers Price Target to $5",
"url": "https://www.benzinga.com/news/26/08/61269612/chardan-capital-downgrades-eyepoint-neutral-lowers-price-target-5",
"source": "benzinga",
"date": "2026-08-18T12:03:50.220000+00:00",
"summary": "Chardan Capital analyst Andreas Argyrides downgrades EyePoint (NASDAQ:EYPT) from Buy to Neutral and lowers the price target from $65 to $5.",
"image": ""
},
{
"title": "HC Wainwright & Co. Downgrades EyePoint to Neutral",
"url": "https://www.benzinga.com/news/26/08/61268705/hc-wainwright-co-downgrades-eyepoint-neutral",
"source": "benzinga",
"date": "2026-08-18T11:29:07.071000+00:00",
"summary": "HC Wainwright & Co. analyst Yi Chen downgrades EyePoint (NASDAQ:EYPT) from Buy to Neutral.",
"image": ""
},
{
"title": "Nike, Meta Platforms, INVO Fertility, EyePoint Pharmaceuticals, and Micron: Why These 5 Stocks Are on Investors' Radars Today",
"url": "https://www.benzinga.com/markets/equities/26/08/61264084/nike-meta-platforms-invo-fertility-eyepoint-pharmaceuticals-and-micron-why-these-5-stocks-are-on-investors-radars-today",
"source": "benzinga",
"date": "2026-08-18T01:39:10.934000+00:00",
"summary": "Major U.S. indices ended lower on Monday, with the Dow Jones Industrial Average falling 0.51% to 53,459.78",
"image": ""
},
{
"title": "Why Is Ocular Therapeutix Stock Gaining Monday?",
"url": "https://www.benzinga.com/news/health-care/26/08/61256847/why-is-ocular-therapeutix-stock-gaining-monday",
"source": "benzinga",
"date": "2026-08-17T17:48:24.449000+00:00",
"summary": "Ocular Therapeutix stock jumps 6% as rival EyePoint misses Phase 3 primary endpoint for wet AMD treatment Duravyu.",
"image": ""
},
{
"title": "JP Morgan Downgrades EyePoint to Neutral",
"url": "https://www.benzinga.com/news/26/08/61255705/jp-morgan-downgrades-eyepoint-neutral",
"source": "benzinga",
"date": "2026-08-17T17:10:42.863000+00:00",
"summary": "JP Morgan analyst Tessa Romero downgrades EyePoint (NASDAQ:EYPT) from Overweight to Neutral.",
"image": ""
},
{
"title": "12 Health Care Stocks Moving In Monday's Intraday Session",
"url": "https://www.benzinga.com/trading-ideas/movers/26/08/61255540/12-health-care-stocks-moving-monday-s-intraday-session",
"source": "benzinga",
"date": "2026-08-17T17:06:16.255000+00:00",
"summary": "Gainers\n\nINVO Fertility (NASDAQ:IVF) shares moved upwards by 108.9% to $2.03 during Monday's regular session. The market value of their outstanding shares is at $1.7 million. As per the press release, Q2 earnings",
"image": ""
},
{
"title": "Jefferies Maintains Buy on EyePoint, Lowers Price Target to $8",
"url": "https://www.benzinga.com/news/26/08/61255476/jefferies-maintains-buy-eyepoint-lowers-price-target-8",
"source": "benzinga",
"date": "2026-08-17T17:03:46.457000+00:00",
"summary": "Jefferies analyst Kambiz Yazdi maintains EyePoint (NASDAQ:EYPT) with a Buy and lowers the price target from $30 to $8.",
"image": ""
},
{
"title": "Gold Gains 1%; NY Empire State Manufacturing Index Rises In August",
"url": "https://www.benzinga.com/markets/market-summary/26/08/61253345/gold-gains-1-ny-empire-state-manufacturing-index-rises-in-august",
"source": "benzinga",
"date": "2026-08-17T16:04:03.685000+00:00",
"summary": "US stocks mixed, S&P 500 drops 0.2%. Dow down 0.34%, NASDAQ up 0.04%. Industrials up 0.2%, consumer staples down 1%. NY Fed's Empire State Index at 20.6.",
"image": ""
},
{
"title": "EyePoint Stock Plummets on Mixed Primary Data From Blindness Drug Study",
"url": "https://www.benzinga.com/trading-ideas/movers/26/08/61249866/eyepoint-stock-plummets-on-mixed-primary-data-from-blindness-drug-study",
"source": "Benzinga",
"date": "2026-08-17 10:40:41",
"summary": "EyePoint Inc. (NASDAQ:EYPT) stock plunged on Monday after the company released topline results from its pivotal Phase 3 LUGANO clinical trial evaluating DURAVYU for the treatment of wet age-related macular degeneration.",
"image": "https://images.financialmodelingprep.com/news/eyepoint-stock-plummets-on-mixed-primary-data-from-blindness-20260817.jpg"
},
{
"title": "EyePoint's eye drug misses main goal in late-stage trial",
"url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eyepoints-eye-drug-misses-main-goal-late-stage-trial-2026-08-17/",
"source": "Reuters",
"date": "2026-08-17 07:16:11",
"summary": "EyePoint said \u200bon Monday its \u200cexperimental eye drug failed to meet its main \u200bgoal in \u200ba late-stage trial.",
"image": "https://images.financialmodelingprep.com/news/eyepoints-eye-drug-misses-main-goal-in-latestage-trial-20260817.jpg"
},
{
"title": "EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU\u2122 2.7mg in Wet AMD",
"url": "https://www.globenewswire.com/news-release/2026/08/17/3345965/0/en/eyepoint-announces-topline-data-from-lugano-the-first-of-two-pivotal-phase-3-clinical-trials-for-duravyu-2-7mg-in-wet-amd.html",
"source": "GlobeNewsWire",
"date": "2026-08-17 07:00:00",
"summary": "\u2013 DURAVYU was non-inferior to on-label aflibercept control (nominal p-value = 0.0096) in an ad hoc analysis excluding a 4% asymmetric cohort (9 of 211 patients) who experienced vision loss (\u2265 15 letters) unrelated to wet AMD; primary endpoint not achieved in full dataset, confoun",
"image": "https://images.financialmodelingprep.com/news/eyepoint-announces-topline-data-from-lugano-the-first-of-20260817.jpg"
},
{
"title": "Eyepoint Pharmaceuticals, Inc. $EYPT Stock Position Boosted by California State Teachers Retirement System",
"url": "https://www.defenseworld.net/2026/08/14/eyepoint-pharmaceuticals-inc-eypt-stock-position-boosted-by-california-state-teachers-retirement-system.html",
"source": "Defense World",
"date": "2026-08-14 03:37:50",
"summary": "California State Teachers Retirement System grew its stake in shares of Eyepoint Pharmaceuticals, Inc. (NASDAQ: EYPT) by 2,158.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 105,101 sh",
"image": "https://images.financialmodelingprep.com/news/eyepoint-pharmaceuticals-inc-eypt-stock-position-boosted-by-california-20260814.png"
},
{
"title": "EyePoint (EYPT) Reports Q2 Loss, Beats Revenue Estimates",
"url": "https://www.zacks.com/stock/news/2968413/eyepoint-eypt-reports-q2-loss-beats-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2968413",
"source": "Zacks Investment Research",
"date": "2026-08-05 10:01:20",
"summary": "EyePoint (EYPT) came out with a quarterly loss of $1.09 per share versus the Zacks Consensus Estimate of a loss of $0.92. This compares to a loss of $0.85 per share a year ago.",
"image": "https://images.financialmodelingprep.com/news/eyepoint-eypt-reports-q2-loss-beats-revenue-estimates-20260805.jpg"
},
{
"title": "EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments",
"url": "https://www.globenewswire.com/news-release/2026/08/05/3339189/0/en/eyepoint-reports-second-quarter-2026-financial-results-and-highlights-recent-corporate-developments.html",
"source": "GlobeNewsWire",
"date": "2026-08-05 07:00:00",
"summary": "\u2013 Topline data from LUGANO pivotal Phase 3 wet AMD clinical trial expected in August 2026 \u2013\u2013 \u2013 Topline data from LUCIA pivotal Phase 3 wet AMD clinical trial anticipated in Q4 2026 \u2013\u2013 \u2013 Pivotal Phase 3 DME clinical trials, COMO and CAPRI, fully enrolled over 480 patients in 5 mon",
"image": "https://images.financialmodelingprep.com/news/eyepoint-reports-second-quarter-2026-financial-results-and-highlights-20260805.jpg"
},
{
"title": "EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU\u2122 for Treatment of Diabetic Macular Edema (DME)",
"url": "https://www.globenewswire.com/news-release/2026/07/30/3335900/0/en/EyePoint-Completes-Enrollment-of-Both-Pivotal-Phase-3-Trials-of-DURAVYU-for-Treatment-of-Diabetic-Macular-Edema-DME.html",
"source": "GlobeNewsWire",
"date": "2026-07-30 07:00:00",
"summary": "\u2013 COMO and CAPRI trials together rapidly enrolled over 480 participants in five months, demonstrating continued enthusiasm for DURAVYU trial participation among retinal specialists and patients \u2013\u2013",
"image": "https://images.financialmodelingprep.com/news/eyepoint-completes-enrollment-of-both-pivotal-phase-3-trials-20260730.jpg"
},
{
"title": "Earnings Preview: EyePoint (EYPT) Q2 Earnings Expected to Decline",
"url": "https://www.zacks.com/stock/news/2963234/earnings-preview-eyepoint-eypt-q2-earnings-expected-to-decline?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2963234",
"source": "Zacks Investment Research",
"date": "2026-07-29 11:06:08",
"summary": "EyePoint (EYPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"image": "https://images.financialmodelingprep.com/news/earnings-preview-eyepoint-eypt-q2-earnings-expected-to-decline-20260729.jpg"
},
{
"title": "EyePoint Appoints Tarek S. Hassan, M.D.",
"url": "https://www.globenewswire.com/news-release/2026/07/13/3326057/0/en/EyePoint-Appoints-Tarek-S-Hassan-M-D-as-Chief-Strategic-Science-Officer.html",
"source": "GlobeNewsWire",
"date": "2026-07-13 07:00:00",
"summary": "Globally renowned retina specialist and key opinion leader to provide strategic guidance across clinical development, commercialization, and pipeline initiatives Globally renowned retina specialist and key opinion leader to provide strategic guidance across clinical development, ",
"image": "https://images.financialmodelingprep.com/news/eyepoint-appoints-tarek-s-hassan-md-20260713.jpg"
},
{
"title": "Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could",
"url": "https://www.fool.com/investing/2026/06/29/will-spacex-stock-double-anytime-soon-no-but-these/",
"source": "The Motley Fool",
"date": "2026-06-29 04:44:00",
"summary": "Unlike SpaceX, ADMA Biologics is already profitable and has a clear path to doubling over the near term. EyePoint Pharmaceuticals could soon be a key player in a $15 billion global market.",
"image": "https://images.financialmodelingprep.com/news/will-spacex-stock-double-anytime-soon-no-but-these-20260629.jpg"
},
{
"title": "EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)",
"url": "https://www.globenewswire.com/news-release/2026/06/16/3312402/0/en/EyePoint-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-16T11:00:00Z",
"summary": "EyePoint, Inc. granted non-statutory stock options to three new employees as inducement awards on June 15, 2026. The company granted options to purchase 39,700 shares at an exercise price of $12.08 per share with a ten-year term and four-year vesting schedule. The grants were app",
"image": "https://ml.globenewswire.com/Resource/Download/3934240c-3155-4c7d-a525-885791fdab8b"
},
{
"title": "EyePoint, Inc. (EYPT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript",
"url": "https://seekingalpha.com/article/4913500-eyepoint-inc-eypt-presents-at-goldman-sachs-47th-annual-global-healthcare-conference-2026",
"source": "Seeking Alpha",
"date": "2026-06-09 17:12:15",
"summary": "EyePoint, Inc. (EYPT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript",
"image": "https://images.financialmodelingprep.com/news/eyepoint-inc-eypt-presents-at-goldman-sachs-47th-annual-20260609.jpg"
},
{
"title": "EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data Nears",
"url": "https://www.marketbeat.com/instant-alerts/eyepoint-pharmaceuticals-eyes-transformative-2026-as-duravyu-phase-3-data-nears-2026-05-26/",
"source": "MarketBeat",
"date": "2026-05-26 12:05:01",
"summary": "Eyepoint Pharmaceuticals NASDAQ: EYPT executives said the company remains on track to report top-line data from its Phase 3 wet age-related macular degeneration program for DURAVYU, also known as EYP-1901, beginning in August, with a second pivotal trial expected to follow about ",
"image": "https://images.financialmodelingprep.com/news/eyepoint-pharmaceuticals-eyes-transformative-2026-as-duravyu-phase-3-20260526.jpg"
},
{
"title": "EyePoint Announces Participation at Upcoming Investor Conferences",
"url": "https://www.globenewswire.com/news-release/2026/05/19/3297309/0/en/EyePoint-Announces-Participation-at-Upcoming-Investor-Conferences.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-19T11:00:00Z",
"summary": "EyePoint, Inc. (EYPT) announced participation in three upcoming healthcare conferences in May-June 2026. The company also reported a third consecutive positive Data Safety Monitoring Committee (DSMC) recommendation for its Phase 3 wet AMD trials of DURAVYU\u2122, with topline data exp",
"image": "https://ml.globenewswire.com/Resource/Download/3934240c-3155-4c7d-a525-885791fdab8b"
},
{
"title": "EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments",
"url": "https://www.globenewswire.com/news-release/2026/05/06/3288642/0/en/EyePoint-Reports-First-Quarter-2026-Financial-Results-and-Highlights-Recent-Corporate-Developments.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-06T11:00:00Z",
"summary": "EyePoint announced Q1 2026 financial results with $223 million in cash runway extending into Q4 2027. The company's lead product DURAVYU is progressing through Phase 3 trials for wet AMD and DME, with topline data expected beginning mid-2026 for wet AMD and Q4 2027 for DME. Howev",
"image": "https://ml.globenewswire.com/Resource/Download/3934240c-3155-4c7d-a525-885791fdab8b"
},
{
"title": "This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter",
"url": "https://www.fool.com/coverage/filings/2026/03/16/this-biotech-stock-up-700-is-still-a-top-holding-despite-a-usd9-3-million-sale-last-quarter/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-03-16T22:23:49Z",
"summary": "Cormorant Asset Management sold 50,000 shares of Praxis Precision Medicines (PRAX) in Q4 2025 for $9.31 million, but the position still increased by $227 million in value due to stock appreciation. PRAX remains Cormorant's largest holding at $280 million. The biotech stock has su",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F1a599f395be31e2f508c3aa7decb988f9ce983b7-1401x1251.png%3Frect%3D76%2C0%2C1251%2C1251%26w%3D384%26h%3D384%26q%3D75%26fit%3Dcrop%26auto%3Dformat&w=1200&op=resize"
}
]
Data:
[
{
"symbol": "EYPT",
"date": "2026-11-04",
"epsActual": null,
"epsEstimated": -0.91722,
"revenueActual": null,
"revenueEstimated": 224462,
"lastUpdated": "2026-08-18"
},
{
"symbol": "EYPT",
"date": "2026-08-05",
"epsActual": -1.09,
"epsEstimated": -1.01,
"revenueActual": 507000,
"revenueEstimated": 451214,
"lastUpdated": "2026-08-18"
},
{
"symbol": "EYPT",
"date": "2026-05-06",
"epsActual": -0.99,
"epsEstimated": -0.79,
"revenueActual": 696000,
"revenueEstimated": 352833,
"lastUpdated": "2026-08-06"
},
{
"symbol": "EYPT",
"date": "2026-03-04",
"epsActual": -0.81,
"epsEstimated": -0.78,
"revenueActual": 620000,
"revenueEstimated": 994464,
"lastUpdated": "2026-06-04"
},
{
"symbol": "EYPT",
"date": "2025-11-05",
"epsActual": -0.85,
"epsEstimated": -0.77,
"revenueActual": 966000,
"revenueEstimated": 1005800,
"lastUpdated": "2026-02-05"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "EYPT",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "EYPT",
"periods": [
{
"file_period": "202604a",
"settlement_date": "20260413",
"quantity_fails": 213,
"price": 14.19
},
{
"file_period": "202604b",
"settlement_date": "20260421",
"quantity_fails": 615,
"price": 15.07
},
{
"file_period": "202606a",
"settlement_date": "20260605",
"quantity_fails": 325,
"price": 12.26
},
{
"file_period": "202606b",
"settlement_date": "20260625",
"quantity_fails": 489,
"price": 14.4
},
{
"file_period": "202607a",
"settlement_date": "20260708",
"quantity_fails": 79890,
"price": 14.02
},
{
"file_period": "202607b",
"settlement_date": "20260729",
"quantity_fails": 30,
"price": 11.96
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "EYPT",
"filingDate": "2026-07-14",
"transactionDate": "2026-07-10",
"reportingCik": "0001630864",
"companyCik": "0001314102",
"transactionType": "M-Exempt",
"securitiesOwned": 17653,
"reportingName": "Duker Jay S.",
"typeOfOwner": "director, officer: President and CEO",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16667,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1314102/000163086426000010/0001630864-26-000010-index.htm"
},
{
"symbol": "EYPT",
"filingDate": "2026-07-14",
"transactionDate": "2026-07-10",
"reportingCik": "0001630864",
"companyCik": "0001314102",
"transactionType": "F-InKind",
"securitiesOwned": 9594,
"reportingName": "Duker Jay S.",
"typeOfOwner": "director, officer: President and CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 8059,
"price": 14.72,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1314102/000163086426000010/0001630864-26-000010-index.htm"
},
{
"symbol": "EYPT",
"filingDate": "2026-07-14",
"transactionDate": "2026-07-10",
"reportingCik": "0001630864",
"companyCik": "0001314102",
"transactionType": "M-Exempt",
"securitiesOwned": 0,
"reportingName": "Duker Jay S.",
"typeOfOwner": "director, officer: President and CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16667,
"price": 0,
"securityName": "Restricted Stock Units",
"url": "https://www.sec.gov/Archives/edgar/data/1314102/000163086426000010/0001630864-26-000010-index.htm"
},
{
"symbol": "EYPT",
"filingDate": "2026-07-02",
"transactionDate": "2026-06-30",
"reportingCik": "0002013623",
"companyCik": "0001314102",
"transactionType": "M-Exempt",
"securitiesOwned": 78001,
"reportingName": "Ribeiro Ramiro",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2437,
"price": 8.26,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1314102/000201362326000012/0002013623-26-000012-index.htm"
},
{
"symbol": "EYPT",
"filingDate": "2026-07-02",
"transactionDate": "2026-06-30",
"reportingCik": "0002013623",
"companyCik": "0001314102",
"transactionType": "M-Exempt",
"securitiesOwned": 75563,
"reportingName": "Ribeiro Ramiro",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2438,
"price": 8.26,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1314102/000201362326000012/0002013623-26-000012-index.htm"
},
{
"symbol": "EYPT",
"filingDate": "2026-07-02",
"transactionDate": "2026-06-30",
"reportingCik": "0002013623",
"companyCik": "0001314102",
"transactionType": "M-Exempt",
"securitiesOwned": 4875,
"reportingName": "Ribeiro Ramiro",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2438,
"price": 8.26,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1314102/000201362326000012/0002013623-26-000012-index.htm"
},
{
"symbol": "EYPT",
"filingDate": "2026-07-02",
"transactionDate": "2026-06-30",
"reportingCik": "0002013623",
"companyCik": "0001314102",
"transactionType": "S-Sale",
"securitiesOwned": 2438,
"reportingName": "Ribeiro Ramiro",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2437,
"price": 15,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1314102/000201362326000012/0002013623-26-000012-index.htm"
},
{
"symbol": "EYPT",
"filingDate": "2026-07-02",
"transactionDate": "2026-06-30",
"reportingCik": "0002013623",
"companyCik": "0001314102",
"transactionType": "M-Exempt",
"securitiesOwned": 2437,
"reportingName": "Ribeiro Ramiro",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2437,
"price": 8.26,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1314102/000201362326000012/0002013623-26-000012-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "EYPT",
"executed_at": "2026-08-18T14:41:31.096000Z",
"size": 1020.0,
"price": 5.28,
"premium": 5385.6,
"volume": 1020.0,
"trade_code": " "
},
{
"ticker": "EYPT",
"executed_at": "2026-08-18T14:42:27.725000Z",
"size": 1000.0,
"price": 5.28,
"premium": 5280.0,
"volume": 1000.0,
"trade_code": "F"
},
{
"ticker": "EYPT",
"executed_at": "2026-08-18T14:42:37.482000Z",
"size": 798.0,
"price": 5.25,
"premium": 4189.5,
"volume": 798.0,
"trade_code": " "
},
{
"ticker": "EYPT",
"executed_at": "2026-08-18T14:42:32.514000Z",
"size": 510.0,
"price": 5.265,
"premium": 2685.1499999999996,
"volume": 510.0,
"trade_code": " "
},
{
"ticker": "EYPT",
"executed_at": "2026-08-18T14:42:27.725000Z",
"size": 500.0,
"price": 5.28,
"premium": 2640.0,
"volume": 500.0,
"trade_code": "F"
},
{
"ticker": "EYPT",
"executed_at": "2026-08-18T14:41:51.653000Z",
"size": 500.0,
"price": 5.3125,
"premium": 2656.25,
"volume": 500.0,
"trade_code": " "
},
{
"ticker": "EYPT",
"executed_at": "2026-08-18T14:41:45.176000Z",
"size": 361.0,
"price": 5.295,
"premium": 1911.495,
"volume": 361.0,
"trade_code": " "
},
{
"ticker": "EYPT",
"executed_at": "2026-08-18T14:42:27.725000Z",
"size": 300.0,
"price": 5.28,
"premium": 1584.0,
"volume": 300.0,
"trade_code": "F"
}
],
"ats": {
"symbol": "EYPT",
"date": "20260817",
"ats_volume": 0,
"total_volume": 26364523,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260817",
"ats_ratio": 0.0
},
{
"date": "20260814",
"ats_ratio": 0.0
},
{
"date": "20260813",
"ats_ratio": 0.0
},
{
"date": "20260812",
"ats_ratio": 0.0
},
{
"date": "20260811",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "EYPT",
"days": [
{
"date": "2026-08-18",
"close": 5.31,
"vwap": 5.19,
"volume": 7634637,
"vwap_discount_pct": -2.31
},
{
"date": "2026-08-17",
"close": 4.87,
"vwap": 4.52,
"volume": 52268276,
"vwap_discount_pct": -7.15
},
{
"date": "2026-08-14",
"close": 14.75,
"vwap": 14.25,
"volume": 2511098,
"vwap_discount_pct": -3.37
},
{
"date": "2026-08-13",
"close": 13.48,
"vwap": 13.43,
"volume": 1202186,
"vwap_discount_pct": -0.35
},
{
"date": "2026-08-12",
"close": 13.53,
"vwap": 13.49,
"volume": 2261368,
"vwap_discount_pct": -0.27
}
],
"avg_vwap_discount_pct": -2.69,
"signal": "Distribution"
},
"options_flow": [
{
"strike": "7.5",
"volume": 223,
"underlying_price": "5.17",
"underlying_symbol": "EYPT",
"premium": "41125.00",
"nbbo_bid": "2.35",
"size": 175,
"option_chain_id": "EYPT260821P00007500",
"delta": "-0.948151396873638",
"open_interest": 4541,
"nbbo_ask": "2.45",
"expiry": "2026-08-21",
"sector": "Healthcare",
"executed_at": "2026-08-18T14:26:00.158451Z",
"implied_volatility": "2.364085844306712",
"price": "2.35",
"option_type": "put"
},
{
"strike": "12.5",
"volume": 61,
"underlying_price": "5.34",
"underlying_symbol": "EYPT",
"premium": "21600.00",
"nbbo_bid": "7.20",
"size": 30,
"option_chain_id": "EYPT260918P00012500",
"delta": "-0.920931118319491",
"open_interest": 624,
"nbbo_ask": "7.30",
"expiry": "2026-09-18",
"sector": "Healthcare",
"executed_at": "2026-08-18T14:05:51.842304Z",
"implied_volatility": "1.745370386793572",
"price": "7.20",
"option_type": "put"
},
{
"strike": "12.5",
"volume": 31,
"underlying_price": "5.33",
"underlying_symbol": "EYPT",
"premium": "21600.00",
"nbbo_bid": "7.00",
"size": 30,
"option_chain_id": "EYPT260918P00012500",
"delta": "-0.928146860581704",
"open_interest": 624,
"nbbo_ask": "7.40",
"expiry": "2026-09-18",
"sector": "Healthcare",
"executed_at": "2026-08-18T14:04:25.814410Z",
"implied_volatility": "1.703545917787138",
"price": "7.20",
"option_type": "put"
},
{
"strike": "7.5",
"volume": 94,
"underlying_price": "5.325",
"underlying_symbol": "EYPT",
"premium": "19200.00",
"nbbo_bid": "2.40",
"size": 80,
"option_chain_id": "EYPT260918P00007500",
"delta": "-0.754676703571838",
"open_interest": 2312,
"nbbo_ask": "2.50",
"expiry": "2026-09-18",
"sector": "Healthcare",
"executed_at": "2026-08-18T14:03:21.934977Z",
"implied_volatility": "1.320305854216275",
"price": "2.40",
"option_type": "put"
},
{
"strike": "10",
"volume": 54,
"underlying_price": "5.2805",
"underlying_symbol": "EYPT",
"premium": "11750.00",
"nbbo_bid": "4.50",
"size": 25,
"option_chain_id": "EYPT260821P00010000",
"delta": "-0.905255746220526",
"open_interest": 2493,
"nbbo_ask": "4.80",
"expiry": "2026-08-21",
"sector": "Healthcare",
"executed_at": "2026-08-18T14:09:24.123706Z",
"implied_volatility": "4.62617126893766",
"price": "4.70",
"option_type": "put"
}
],
"net_premium": {
"ticker": "EYPT",
"net_call_premium": "-26789.00",
"net_put_premium": "-89040.00",
"call_premium": "224917.00",
"put_premium": "205530.00",
"bullish_premium": "210549.00",
"bearish_premium": "148298.00",
"put_call_ratio": "0.32469258889996676637",
"iv_rank": "22.5781",
"implied_move_perc": "0.218000",
"gex_ratio": "4.0830643789485029",
"gex_net_change": "-27730.8656",
"gex_call": "238018.7073",
"gex_put": "-971845.7053",
"gex_net": -733826.998,
"gex_call_delta": "619668.7554",
"gex_put_delta": "-4092608.6362",
"gex_date": "2026-08-18"
},
"hot_chains": [
{
"underlying_symbol": "EYPT",
"expires": "2026-09-18",
"open_interest": 2222,
"option_type": "call",
"delta": 0.623069422786266,
"ask_volume": 301,
"last_price": "0.75",
"implied_volatility": "1.136887374894985",
"gamma": 0.2123658598580457,
"avg_price": "0.8015557830092118730808597753",
"bid_volume": 594,
"nbbo_ask": "0.80",
"strike": "5",
"option_symbol": "EYPT260918C00005000",
"total_premium": "78312.00",
"iv": 1.164781564565841,
"volume": 977,
"nbbo_bid": "0.75"
},
{
"underlying_symbol": "EYPT",
"expires": "2026-08-21",
"open_interest": 1828,
"option_type": "call",
"delta": 0.673373894950826,
"ask_volume": 275,
"last_price": "0.32",
"implied_volatility": "0.863666810623763",
"gamma": 0.543558362373731,
"avg_price": "0.4016071428571428571428571431",
"bid_volume": 363,
"nbbo_ask": "0.60",
"strike": "5",
"option_symbol": "EYPT260821C00005000",
"total_premium": "33735.00",
"iv": 1.345460696191199,
"volume": 840,
"nbbo_bid": "0.30"
},
{
"underlying_symbol": "EYPT",
"expires": "2026-08-21",
"open_interest": 861,
"option_type": "put",
"delta": -0.01547088872195194,
"ask_volume": 1,
"last_price": "0.04",
"implied_volatility": "5.21184280200864",
"gamma": 0.01966309570854935,
"avg_price": "0.0101090909090909090909090909",
"bid_volume": 274,
"nbbo_ask": "0.05",
"strike": "2.5",
"option_symbol": "EYPT260821P00002500",
"total_premium": "278.00",
"iv": 4.01062549110949,
"volume": 275,
"nbbo_bid": "0.00"
},
{
"underlying_symbol": "EYPT",
"expires": "2026-10-16",
"open_interest": 207,
"option_type": "call",
"delta": 0.633602975114796,
"ask_volume": 44,
"last_price": "1.10",
"implied_volatility": "1.125435559532249",
"gamma": 0.1496020894875252,
"avg_price": "1.0949999999999999999999999999",
"bid_volume": 226,
"nbbo_ask": "1.20",
"strike": "5",
"option_symbol": "EYPT261016C00005000",
"total_premium": "29565.00",
"iv": 1.189632624302019,
"volume": 270,
"nbbo_bid": "1.10"
},
{
"underlying_symbol": "EYPT",
"expires": "2026-08-21",
"open_interest": 4541,
"option_type": "put",
"delta": -0.960507578014406,
"ask_volume": 9,
"last_price": "2.25",
"implied_volatility": "2.024879149335024",
"gamma": 0.0843870518990371,
"avg_price": "2.3096506550218340611353711790",
"bid_volume": 220,
"nbbo_ask": "2.35",
"strike": "7.5",
"option_symbol": "EYPT260821P00007500",
"total_premium": "52891.00",
"iv": 2.04938140819771,
"volume": 229,
"nbbo_bid": "2.15"
},
{
"underlying_symbol": "EYPT",
"expires": "2026-09-18",
"open_interest": 138,
"option_type": "call",
"delta": 0.0937906113602571,
"ask_volume": 51,
"last_price": "0.10",
"implied_volatility": "1.530984526295265",
"gamma": 0.07565242302093,
"avg_price": "0.1003067484662576687116564416",
"bid_volume": 94,
"nbbo_ask": "0.15",
"strike": "10",
"option_symbol": "EYPT260918C00010000",
"total_premium": "1635.00",
"iv": 1.441372081267529,
"volume": 163,
"nbbo_bid": "0.05"
},
{
"underlying_symbol": "EYPT",
"expires": "2026-09-18",
"open_interest": 252,
"option_type": "call",
"delta": 0.229671800309007,
"ask_volume": 125,
"last_price": "0.25",
"implied_volatility": "1.340002836157253",
"gamma": 0.1509134333407909,
"avg_price": "0.2506896551724137931034482760",
"bid_volume": 17,
"nbbo_ask": "0.25",
"strike": "7.5",
"option_symbol": "EYPT260918C00007500",
"total_premium": "3635.00",
"iv": 1.309373007573368,
"volume": 145,
"nbbo_bid": "0.15"
},
{
"underlying_symbol": "EYPT",
"expires": "2026-08-21",
"open_interest": 9764,
"option_type": "put",
"delta": -0.315981597484132,
"ask_volume": 38,
"last_price": "0.15",
"implied_volatility": "1.384558944213498",
"gamma": 0.450608022007209,
"avg_price": "0.2033606557377049180327868852",
"bid_volume": 31,
"nbbo_ask": "0.20",
"strike": "5",
"option_symbol": "EYPT260821P00005000",
"total_premium": "2481.00",
"iv": 1.582326006770576,
"volume": 122,
"nbbo_bid": "0.15"
}
],
"gamma_profile": {
"ticker": "EYPT",
"spot": 5.2422,
"date": "2026-08-18",
"flip_point": null,
"net_gex": -733827.0,
"call_walls": [
{
"strike": 5.0,
"gex": 139663.8
},
{
"strike": 10.0,
"gex": 28842.26
},
{
"strike": 7.5,
"gex": 17709.0
}
],
"put_walls": [
{
"strike": 5.0,
"gex": -559600.18
},
{
"strike": 10.0,
"gex": -182517.12
},
{
"strike": 7.5,
"gex": -162900.78
}
],
"by_strike": [
{
"strike": 2.5,
"call_gex": 528.26,
"put_gex": -30316.67,
"net_gex": -29788.4
},
{
"strike": 5.0,
"call_gex": 139663.8,
"put_gex": -559600.18,
"net_gex": -419936.38
},
{
"strike": 7.5,
"call_gex": 17709.0,
"put_gex": -162900.78,
"net_gex": -145191.78
},
{
"strike": 10.0,
"call_gex": 28842.26,
"put_gex": -182517.12,
"net_gex": -153674.86
},
{
"strike": 12.5,
"call_gex": 17118.75,
"put_gex": -10974.03,
"net_gex": 6144.72
},
{
"strike": 15.0,
"call_gex": 15317.92,
"put_gex": -22825.05,
"net_gex": -7507.13
},
{
"strike": 17.5,
"call_gex": 7917.21,
"put_gex": -1273.27,
"net_gex": 6643.94
},
{
"strike": 20.0,
"call_gex": 2461.81,
"put_gex": -1412.65,
"net_gex": 1049.16
},
{
"strike": 22.5,
"call_gex": 1187.38,
"put_gex": -14.24,
"net_gex": 1173.14
},
{
"strike": 25.0,
"call_gex": 1812.09,
"put_gex": -9.68,
"net_gex": 1802.41
},
{
"strike": 30.0,
"call_gex": 996.01,
"put_gex": -2.04,
"net_gex": 993.97
},
{
"strike": 35.0,
"call_gex": 4464.22,
"put_gex": 0.0,
"net_gex": 4464.22
}
]
},
"oi_changes": {
"net_call_oi_change": -20,
"net_put_oi_change": -25052,
"top": [
{
"strike": "10",
"oi_change": -17012,
"type": "put"
},
{
"strike": "10",
"oi_change": -2591,
"type": "put"
},
{
"strike": "12.5",
"oi_change": -2548,
"type": "put"
},
{
"strike": "7.5",
"oi_change": -2166,
"type": "put"
},
{
"strike": "5",
"oi_change": -849,
"type": "put"
}
]
}
}
Data:
{
"vix": 14.63,
"sp500": 7798.99,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.48,
"hy_spread": 2.71,
"treasury": {
"date": "2026-08-14",
"month1": 3.79,
"month2": 3.81,
"month3": 3.86,
"month6": 3.95,
"year1": 3.98,
"year2": 4.17,
"year3": 4.24,
"year5": 4.36,
"year7": 4.51,
"year10": 4.68,
"year20": 5.25,
"year30": 5.25
},
"events": [
{
"title": "FOMC Meeting Minutes",
"currency": "USD",
"date": "2026-08-19",
"time_utc": "18:00",
"impact": "High",
"forecast": null,
"previous": null,
"actual": null,
"minutes_until": 1678
}
]
}
Data:
{
"days": 43,
"patterns": [
{
"name": "VWAP Touch",
"count": 43,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 43,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 43,
"pct": 100
},
{
"name": "Woodie Pivot Touch",
"count": 42,
"pct": 98
},
{
"name": "ORB Breakout",
"count": 39,
"pct": 91
},
{
"name": "PDH/PDL Touch",
"count": 38,
"pct": 88
},
{
"name": "Open Retracement",
"count": 31,
"pct": 72
},
{
"name": "Gap Fill",
"count": 29,
"pct": 67
},
{
"name": "Darvas Box",
"count": 15,
"pct": 35
},
{
"name": "High Vol Open",
"count": 12,
"pct": 28
},
{
"name": "Power Hour",
"count": 6,
"pct": 14
}
]
}